A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Mayo Clinic
Elevation Oncology
Shanghai PerHum Therapeutics Co., Ltd.
Pfizer
pharmaand GmbH
MacroGenics
Tocagen Inc.
CureOne